KARPAS 707H Human Myeloma cell line
Technology No.
KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.
Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio.
-
swap_vertical_circlemode_editAuthors (1)Abraham Karpas
-
swap_vertical_circlelibrary_booksReferences (2)
- A Karpas, A Dremucheva, B H Czepulkowski (February 13, 2001), A human myeloma cell line suitable for the generation of human monoclonal antibodies, Proceedings of the National Academy of Sciences, 90(4), 1799–1804
- M Vaisbourd, O Ignatovich, A Dremucheva, A Karpas, G Winter (7 July 2004), Molecular characterization of human monoclonal antibodies derived from fusions of tonsil lymphocytes with a human myeloma cell line, Hybridoma and Hybridomics, 20, 287-292
-
swap_vertical_circlecloud_downloadSupporting documents (1)Product brochureKARPAS 707H Human Myeloma cell line.pdfAdditional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Sign up to our newsletter
If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.